Manufacturing

  1. Meeting Cell Therapy Market Demand 1/14/2021

    The commercial success of a cell-based therapeutic depends on a scalable, automated manufacturing process. But how can companies ensure their manufacturing processes are up to meeting the needs and market demand of the rapidly evolving cell therapy field? Our annual breakfast briefing at the Phacilitate Leaders World conference 2020 in Miami tackled this and other current topics.

  2. Ori Spotlight: How Early Automation Strategies Reduce Costs And Improve Patient Access 6/20/2025

    A pioneer in regenerative medicine reveals how to bridge the gap from research to reality. Learn how early automation and strategic partnerships can slash costs and expand patient access to therapies.

  3. Simplifying Bioprocess Data Collection 2/17/2023

    Centralized bioprocess data collection and aggregation lowers the risk of data loss during any manual retrieval process. Discover a solution that helps you meet data storage and reporting requirements.

  4. Explore The M Lab Collaboration Center In Burlington MA 9/19/2022

    Our global network of scientific experts, innovative technologies, and non-GMP facilities, empower drug developers of all sizes to achieve manufacturing excellence and innovation through collaborative exploration and learning. Explore 1 of our 8 global facilities today.

  5. Key Functions Of The ÄKTA Oligosynt Synthesizer 2/16/2023

    Discover a compact, fully automated oligonucleotide synthesizer for robust, scalable process development. Learn how it can help establish a robust and reproducible oligo synthesis process.

  6. Introducing Our Single Use Mixing System 11/3/2022

    Ross Acucena, applications director, and Donnie Beers, product manager, introduce our single-use mixing system made to be deployed rapidly to help manufacturers meet development, supply, and cost objectives.

  7. Executive Roundtable: Cell Therapy Predictions For 2025 And Beyond 12/17/2024

    In this executive roundtable discussion, Bioprocess Online editor Tyler Menichiello is joined by CEO, co-founder, and president of Ossium Health, Kevin Caldwell, CSO of FibroBiologics, Hamid Khoja, Ph.D., and president and acting CEO of Triumvira Immunologics, Rob Williamson. The panelists share their predictions and thoughts on the industry’s direction heading into 2025. They cover manufacturing trends (noting opportunities for improvements in cell therapy manufacturing), AI adoption, regulatory concerns, and the potentially challenging funding environment ahead. 

  8. What Is Causing Limited Bioavailability 4/21/2025

    Discover how this label-free whole-body QMSI combined with plasma LC-MS/MS can help identify the root causes of limited bioavailability and guide smarter optimization strategies early in development.

  9. Manufacturing Life-Saving Gene Therapies 2/24/2021

    Take a look behind the scenes and hear firsthand about the commitment to patients and clients at Andelyn Biosciences.

  10. Freezing Studies For Single-Use Solutions: Therapy Containment/Protection (Part 3) 5/14/2024

    Watch part 3 of a four-part series, "Four Common Types Of Cryogenic Studies For Advanced Therapies," to learn about therapy containment/protection studies.